Back to top

AbCellera Biologics Stock Hits New 52-Week High as Recent Insider Buying Moves Into Profit

AbCellera Biologics Inc (ABCL) hit a 52-week high of $7.27, up 164.36% from its $2.75 low. Insider purchases totaling 278,057 shares at $3.27–$4.77 remain profitable, highlighting confidence despite uncertainty about the company's future fundamentals and market outlook..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AbCellera Biologics Inc. (ABCL)